
About this episode
British minister Dehenna Davison recently resigned from government, explaining that chronic migraines were making it impossible for her to do her job. Her announcement coincided with a new drug for acute migraines being recommended for use in the NHS. Madeleine Finlay meets Prof Peter Goadsby, whose pioneering research underpins the new drug, to find out about the advances we’ve made in understanding migraines, and whether we might one day be able to wave goodbye to migraines for good. Help support our independent journalism at theguardian.com/sciencepod
Get every episode summarized
Each time Science Weekly publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from Science Weekly

Muons, massive waves and restored sight: the winners at the ‘Oscars of science’
Science Weekly
Apr 23, 202616:19failed

Mythos: are fears over new AI model panic or PR?
Science Weekly
Apr 21, 202615:50failed

The surprising value of boring chats, ‘super El Niño’ and Alzheimer’s evidence r...
Science Weekly
Apr 16, 202620:45failed

Helium: the invisible gas that powers AI, and why it’s in short supply
Science Weekly
Apr 14, 202616:19failed